Michelle Samuel
Sunnybrook Health Sciences Centre
17 Papers
8 Citations
Michelle Samuel is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Current Perspectives on Coronary Chronic Total Occlusions: The Canadian Multicenter Chronic Total Occlusions Registry
Paul Fefer,Paul Fefer,Merril L. Knudtson,Asim N. Cheema,P. Diane Galbraith,Azriel B. Osherov,Sergey Yalonetsky,Sharon Gannot,Michelle Samuel,Max Weisbrod,Daniel Bierstone,John D. Sparkes,Graham A. Wright,Bradley H. Strauss +13 more
TL;DR: Chronic total occlusions are common in contemporary catheterization laboratory practice and Prospective studies are needed to ascertain the benefits of treatment strategies of these complex patients.
778
Native coronary artery patency after coronary artery bypass surgery.
David Pereg,Paul Fefer,Michelle Samuel,Rafael Wolff,Andrew Czarnecki,Saswata Deb,John D. Sparkes,S. Fremes,Bradley H. Strauss +8 more
TL;DR: CTO of surgically bypassed coronary arteries 1 year after coronary artery bypass grafting is extremely common and clinical and angiographic predictors for the development of a chronic total occlusion (CTO) are identified.
81
Ventricular tachycardia burden and mortality: association or causality?
TL;DR: In this article , the authors present the evidence to support association and causation hypotheses for the relationship between ventricular tachycardia (VT) burden and risk of mortality and indicate potential gaps in evidence.
34
Long-term Follow-up of Coronary Artery Bypass Patients With Preoperative and New Postoperative Native Coronary Artery Chronic Total Occlusion.
David Pereg,Paul Fefer,Paul Fefer,Michelle Samuel,Mony Shuvy,Saswata Deb,John D. Sparkes,S. Fremes,Bradley H. Strauss +8 more
TL;DR: In patients undergoing CABG, both preoperative CTOs and newCTOs that develop 1 year after surgery are associated with adverse long-term clinical outcomes.
22
Statin therapy prevents expansive remodeling in venous bypass grafts.
Beiping Qiang,Jonathan Toma,Hiroko Fujii,Azriel B. Osherov,Nafiseh Nili,John D. Sparkes,Paul Fefer,Michelle Samuel,Jagdish Butany,Howard Leong-Poi,Bradley H. Strauss +10 more
TL;DR: Atorvastatin inhibits both expansive remodeling and intimal hyperplasia in arterialized VG, likely through inhibition of macrophage infiltration and reduction of tissue proteolytic activity, and may be important for preventing VG atherosclerosis and late VG failure.
21